CellSeed Inc.

2026/11/03 19:58 Updated
Market Cap: $45.7M (¥7.2B)
Stock Price: $1.16 (¥183)
Exchange Rate: 1 USD = ¥157.98

Notice Regarding Monthly Exercise Status of the 25th Stock Acquisition Rights (with Exercise Price Adjustment Clause)

Disclosed the October 2026 monthly exercise status of the 25th stock acquisition rights issued in December 2025. Of 113,100 shares granted, 1,131 units were exercised, representing an exercise ratio of 1.31%. Unexercised units at month-end were 36,135 shares, compared with 37,266 shares at the end of the previous month. Exercise dates include October 9 and October 21.

Importance:
Page Updated: November 2, 2026
IR Disclosure Date: November 2, 2026

Key Figures

  • Granted shares: 113,100 shares
  • Number of stock acquisition rights exercised: 1,131 units
  • Total number of stock acquisition rights issued: 86,000 units

AI要約

Monthly Disclosure of Stock Acquisition Rights Exercise Status

CellSeed Inc. has disclosed the monthly exercise status of the 25th stock acquisition rights (with an exercise price adjustment clause). For the subject month, the number of shares granted was 113,100 shares, of which 1,131 units were actually exercised and converted into new shares. The exercise ratio against the total issued was 1.31%, and unexercised shares at month-end totaled 36,135 shares. Exercise dates primarily included multiple days such as October 9 and October 21. The number of unexercised shares decreased from 37,266 shares at the end of the previous month.

Impact and Background

This month's exercises were relatively small in scale, and the overall exercise ratio remained low. The number of unexercised shares continues at a certain level, and dilution may vary depending on future exercise trends. References were made to previously disclosed information such as third-party allotments, and the application status of issuance conditions and exercise provisions is a point of attention.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

CellSeed Inc.

Company overview · Stock price · Financial data · All IR

View company page →